SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-058654
Filing Date
2024-05-13
Accepted
2024-05-13 16:09:19
Documents
19
Period of Report
2024-05-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20240513.htm   iXBRL 8-K 36911
2 EX-99.1 cytk-ex99_1.htm EX-99.1 61070
3 EX-99.2 cytk-ex99_2.htm EX-99.2 68218
4 GRAPHIC img114956760_0.jpg GRAPHIC 7836
5 GRAPHIC img114956760_1.jpg GRAPHIC 60247
6 GRAPHIC img114956760_2.jpg GRAPHIC 122115
7 GRAPHIC img114956760_3.jpg GRAPHIC 80197
8 GRAPHIC img114956760_4.jpg GRAPHIC 61474
9 GRAPHIC img115880281_0.jpg GRAPHIC 7836
  Complete submission text file 0000950170-24-058654.txt   764419

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20240513.xsd EX-101.SCH 23887
22 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20240513_htm.xml XML 4536
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 24939096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)